The trademark application FANSKYA mozafancogene autotemcel was filed by Rocket Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 9, 2023, and it was registered by office on January 16, 2024 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on February 11, 2024.
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for the treatment of genetic diseases and disorders.
The mark was filed in class 42 with Research and development of pharmaceuticals for the treatment of genetic diseases and disorders and medical and scientific research services in the field of genetic disease and disorder treatment..
The mark was filed in class 44 with following description of goods:
Providing information in the field of genetic diseases and disorders
Providing information in the field of genetic diseases and disorders treatment
Providing links to the web sites of others featuring information about genetic diseases and disorders
Providing links to the web sites of others in the field of the diagnosis and treatment of genetic diseases and disorders.